UNSPSC 85532558: Occlusion of hepatic vein with extraluminal device, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of hepatic vein with extraluminal device, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06L40CZ

UNSPSC 85532558 "Occlusion of hepatic vein with extraluminal device, open approach" is a Commodity code that does not align with the state and local contract opportunities posted under it. The code nominally describes a surgical procedure for hepatic vein occlusion; however, recent opportunities solicited under this code span occupational medical surveillance, pharmacy benefit management, disability medical evaluations, surgical benefit carve-outs for employee health plans, temporary health professional staffing, and specialty medical services for detained youth. None of these solicitations involve hepatic vein occlusion devices or related interventional procedures. The mismatch suggests the code has been applied to opportunities outside its clinical scope, or the opportunities have been miscoded in the source system.

The issuing bodies include city retirement offices (Phoenix), counties (Santa Clara, Harris, Collier), state transportation departments (Washington State Department of Transportation), and municipal health systems (Long Beach, Santa Clara Health System). Representative recent opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026, $750,000 over five years), the Washington State Department of Transportation's RFP for occupational medical surveillance across 14 ferry system locations (RFP20260825, due October 9, 2026), and Collier County's RFP for pharmacy benefit management services (258414, due April 9, 2026, approximately $8.7 million annually). Activity spans Arizona, Washington, California, and Florida, with no concentration evident. Given the absence of relevant clinical procurement under the code's stated scope, this category warrants exclusion from active pursuit strategies.